ImadA.TabbaraMD

PubMed

• 10 citations
  PARP Inhibitors in Prostate Cancer.
  Kabir Grewal, Kayanaat Grewal, Imad A. Tabbara> ;Anticancer Research. 2021 Feb 1
• 5 citations
  Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series.
  Ralph L. Millett, Anita Aggarwal, Imad A. Tabbara, Samah Nassereddine> ;Anticancer Research. 2019 Aug 1
• 7 citations
  Novel Immunotherapeutic Agents for the Treatment of Multiple Myeloma.
  Hind Rafei, Faysal Haroun, Imad A. Tabbara> ;American Journal of Clinical Oncology. 2019 Mar 1
• 13 citations
  Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy.
  Samah Nassereddine, Coen J Lap, Imad A. Tabbara> ;Oncotargets and Therapy. 2018 Dec 28
• 11 citations
  Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
  Ralph L. Millett, Jacob Elkon, Imad A. Tabbara> ;Anticancer Research. 2018 Sep 1
• 11 citations
  Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
  Samah Nassereddine, Saud Alsubait, Imad A. Tabbara> ;Anticancer Research. 2018 May 1
• 8 citations
  Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study
  John Mascarenhas, Elizabeth Virtgaym, Marina Stal, H. Blacklock, Aaron T. Gerds, Ruben A. Mesa, Peter Ganly, David S. Snyder, Imad A. Tabbara, Douglas Tremblay, Erin M...> ;Annals of Hematology. 2018 Apr 3
• 50 citations
  The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia.
  Samah Nassereddine, Coen J Lap, Faysal Haroun, Imad A. Tabbara> ;Annals of Hematology. 2017 Oct 31
• 24 citations
  PD-1 signaling and inhibition in AML and MDS
  Faysal Haroun, Sade A. Solola, Samah Nassereddine, Imad A. Tabbara> ;Annals of Hematology. 2017 Jun 22
• 15 citations
  Erdheim-Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic Advances.
  Faysal Haroun, Imad A. Tabbara> ;Anticancer Research. 2017 Jun 21
• 2 citations
  Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.
  Aleksandra Vidisheva, James Wang, Tanya M. Spektor, Jacob D. Bitran, Jose Lutzky, Imad A. Tabbara, Joseph Z. Ye, Sikander Ailawadhi, Laura Stampleman, Ronald G. Steis,...> ;Supportive Care in Cancer. 2017 Apr 28
• 113 citations
  Acute Graft Versus Host Disease: A Comprehensive Review.
  Samah Nassereddine, Hind Rafei, Ehab El-Bahesh, Imad A. Tabbara> ;Anticancer Research. 2017 Apr 1
• 61 citations
  Immune-based Therapies for Non-small Cell Lung Cancer.
  Hind Rafei, Ehab El-Bahesh, Antoine Finianos, Samah Nassereddine, Imad A. Tabbara> ;Anticancer Research. 2017 Feb 1
• Anaemia with inflammation responding to lenalidomide.
  Faysal Haroun, Andrew Mener, Jacob Elkon, Imad A. Tabbara> ;BMJ Case Reports. 2016 Oct 13
• 1 citations
  Case of CML lymphoid blast crisis presenting as bilateral breast masses.
  Aneesha Hossain, Kanika Gupta, Andrew S Mener, Imadeddine Tabbara> ;BMJ Case Reports. 2016 Aug 10
• 10 citations
  Chronic Lymphocytic Leukemia: Current Concepts.
  Eun-mi Yu, Adam Kittai, Imad A. Tabbara> ;Anticancer Research. 2015 Oct 1
• 20 citations
  Emerging therapies in multiple myeloma.
  Joelle El-Amm, Imad A. Tabbara> ;American Journal of Clinical Oncology. 2015 Jun 1
• 2 citations
  Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remission.
  Adam Kittai, Eun-mi Yu, Imad A. Tabbara> ;BMJ Case Reports. 2014 Dec 23
• 63 citations
  Complications of Allogeneic Hematopoietic Stem Cell Transplantation
  Karim Arnaout, Nihar Patel, Maneesh Jain, Joelle El-Amm, Farah Amro, Imad A. Tabbara> ;Cancer Investigation. 2014 Jul 8
• 24 citations
  Erdheim-Chester disease: a comprehensive review.
  Ahmed Maher Abdelfattah, Karim Arnaout, Imad A. Tabbara> ;Anticancer Research. 2014 Jul 1
• 5 citations
  Treatment of acute promyelocytic leukemia.
  Ehab Elbahesh, Nihar Patel, Imad A. Tabbara> ;Anticancer Research. 2014 Apr 1
• 77 citations
  Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.
  Jeffrey Vacirca, Peter. I. Acs, Imad A. Tabbara, Peter Rosen, Peter P. Lee, Eric B. Lynam> ;Annals of Hematology. 2014 Mar 1
• 4 citations
  Primary cutaneous anaplastic large-cell lymphoma.
  Edward Perry, Jay Karajgikar, Imad A. Tabbara> ;American Journal of Clinical Oncology. 2013 Oct 1
• 2 citations
  Spontaneous regression of classical Hodgkin lymphoma: a case report and review of the literature.
  Amr Mohsen, Hady Ghanem, Jehan El-Bayoumi, Imad A. Tabbara> ;Clinical Advances in Hematology & Oncology. 2012 Nov 1
• 19 citations
  Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics
  Hady Ghanem, Niki Tank, Imad A. Tabbara> ;American Journal of Hematology. 2012 Jan 1
• Join now to see all

Abstracts/Posters

• The Impact of Diagnosis to Treatment Interval on the Outcome of Patients with Acute Myeloid Leukemia
  Imad A. Tabbara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• WVOS Spring Membership Conference - Clinical and Legislative Issues Impacting Cancer Care in West Virginia 
  West Virginia Oncology Society (WVOS), Daniels, West Virginia - 4/19/2013